Focused ultrasound for prostate cancer
Part of Cancer, Kidney & urinary clinical trials.
This trial tests a new focused ultrasound device (FPG500) for men with prostate cancer that hasn't spread. It may be an option for men with low-risk cancer choosing monitoring or surgery, or high-risk cancer planning surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have prostate cancer that has not spread to other parts of the body.
- Your cancer is diagnosed as low-risk, high-risk, or locally advanced.
- If your cancer is high-risk or locally advanced, you are planning to have surgery.
- If your cancer is low-risk, you are either planning surgery or choosing active surveillance (monitoring without immediate treatment).
- You have not had any other cancer before or at the same time.
- You are not currently taking hormone therapy or other medications for prostate cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether a high-intensity focused ultrasound treatment can help people with localized prostate cancer while still avoiding traditional full-dose treatment for some patients. It may be an option for certain intermediate-risk cases where the cancer is confined to the prostate.
This trial tests combining a focused ultrasound treatment (high-intensity focused ultrasound) with a new type of hormone therapy for men with advanced prostate cancer that has spread. The goal is to see if this combination can help control the cancer better than hormone therapy alone.
This trial tests if a focused ultrasound treatment can safely and effectively treat prostate cancer that has come back after radiation therapy. The ultrasound uses sound waves to heat and destroy cancer cells in a specific area of the prostate while sparing healthy tissue.
This trial tests a laser treatment that targets only the cancerous part of the prostate. It may be an option for men with intermediate-risk prostate cancer who do not want their entire prostate removed.
This trial tests a gentler treatment called focal therapy that targets only the part of the prostate with cancer. It's for men whose prostate cancer has a Gleason score of 7, low PSA, and hasn't spread outside the prostate.
This trial tests a more precise radiation therapy that targets tumors seen on MRI or special scans, aiming to treat prostate cancer while reducing side effects. It is for men who have not had prostate surgery or previous radiation to the area.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.